Fabre-Kramer Pharmaceuticals, Inc. Email Format

Mental Health CareTexas, United States2-10 Employees

Fabre-Kramer Pharmaceuticals, Inc. is a small pharmaceutical company focused on mental health care, identifying, developing, and commercializing psychotropic drugs. Its leadership brings more than four decades of experience in the clinical development of psychotropic therapies and has conducted pivotal studies that supported several FDA-approved psychiatric medicines. The company has conducted research across depression, anxiety, schizophrenia, bipolar disorder, social phobia, and sleep disorders, applying deep evaluation of candidate compounds—covering receptor activity, efficacy, tolerability, side effect profiles, formulation, administration, and manufacturing considerations. Its strategy is to bring to market advanced medications aimed at unmet medical needs, including identifying and acquiring promising psychotropic drugs from major pharmaceutical companies and other sources.

Based in Houston, Texas, Fabre-Kramer operates with a compact team. A recent development includes a June 2025 collaboration with Aytu BioPharma to commercialize Exxua (gepirone) in the United States for major depressive disorder.

Get verified Fabre-Kramer Pharmaceuticals, Inc. emails free

Company overview Employee directory